Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 500 entries
View as:

Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)

Phase: N/A Priority: Normal
NCT ID: NCT00729651 Org: User:
Start: 03/20/08 End: 04/10/09 Due: 04/10/10

Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)

Phase: N/A Priority: Normal
NCT ID: NCT02741271 Org: User:
Start: 05/11/16 End: 12/04/17 Due: 12/04/18

The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384)

Phase: N/A Priority: Normal
NCT ID: NCT00755794 Org: User:
Start: 06/30/06 End: 09/30/07 Due: 09/30/08

Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00381485 Org: User:
Start: 07/01/06 End: 01/01/08 Due: 01/01/09

A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)

Phase: N/A Priority: Normal
NCT ID: NCT00489346 Org: User:
Start: 10/31/01 End: 06/30/02 Due: 06/30/03

A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)

Phase: N/A Priority: Normal
NCT ID: NCT00389740 Org: User:
Start: 04/02/01 End: 01/16/03 Due: 01/16/04

A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)

Phase: N/A Priority: Normal
NCT ID: NCT00157937 Org: User:
Start: 02/28/03 End: 06/30/05 Due: 06/30/06

Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)

Phase: N/A Priority: Normal
NCT ID: NCT00406783 Org: User:
Start: 08/31/06 End: 11/30/07 Due: 11/30/08

Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)

Phase: N/A Priority: Normal
NCT ID: NCT01005056 Org: User:
Start: 05/31/05 End: 03/31/09 Due: 03/31/10

Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00358527 Org: User:
Start: 05/31/06 End: 11/30/06 Due: 11/30/07

Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)

Phase: N/A Priority: Normal
NCT ID: NCT00202904 Org: User:
Start: 05/31/05 End: 10/31/06 Due: 10/31/07

Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00654628 Org: User:
Start: 08/01/07 End: 07/01/09 Due: 07/01/10

Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)

Phase: N/A Priority: Normal
NCT ID: NCT00974571 Org: User:
Start: 11/30/01 End: 05/31/02 Due: 05/31/03

Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)

Phase: N/A Priority: Normal
NCT ID: NCT00702546 Org: User:
Start: 12/31/06 End: 12/31/08 Due: 12/31/09

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)

Phase: N/A Priority: Normal
NCT ID: NCT00212836 Org: User:
Start: 04/21/05 End: 08/02/07 Due: 08/02/08

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1)

Phase: N/A Priority: Normal
NCT ID: NCT01206517 Org: User:
Start: 07/18/10 End: 08/04/11 Due: 08/04/12

Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00739050 Org: User:
Start: 09/19/07 End: 02/01/08 Due: 02/01/09

A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)

Phase: N/A Priority: Normal
NCT ID: NCT01307033 Org: User:
Start: 03/29/11 End: 12/04/12 Due: 12/04/13

9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00143182 Org: User:
Start: 01/07/05 End: 06/28/06 Due: 06/28/07

A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)

Phase: N/A Priority: Normal
NCT ID: NCT00311844 Org: User:
Start: 03/01/05 End: 05/28/05 Due: 05/28/06

The Effect of Montelukast on Difficulty in Breathing After Exercise in Pediatric Patients (MK0476-377)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00534976 Org: User:
Start: 02/29/08 End: 03/31/10 Due: 03/31/11

Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)

Phase: N/A Priority: Normal
NCT ID: NCT00442559 Org: User:
Start: 01/31/05 End: 10/31/07 Due: 10/31/08

A Phase 2 Study of E6005 in Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01461941 Org: User:
Start: 12/31/11 End: 01/31/13 Due: 01/31/14

Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016)

Phase: N/A Priority: Normal
NCT ID: NCT00702585 Org: User:
Start: 08/01/01 End: 10/15/02 Due: 10/15/03

Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)

Phase: N/A Priority: Normal
NCT ID: NCT00413062 Org: User:
Start: 06/30/06 End: 08/31/08 Due: 08/31/09